Abstract
Choosing between continuing vitamin K antagonists (<scp>VKA</scp>) or switching to a direct oral anticoagulant in currently well‐controlled patients on <scp>VKA</scp> for atrial fibrillation: a randomised controlled trial (<scp>GAI</scp>nN)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
